drugset / Trial / NCT01426113

A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

NCT01426113

Phase 3 Terminated 6 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of a new formulation of bimatoprost ophthalmic solution compared to timolol ophthalmic solution in the treatment of paediatric patients with glaucoma.

Timeline

Start
2011-09
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 1 unknown Other
Comparator Timolol Other / unclassified 1 unknown Other

Indications